FIELD: organic chemistry, amino acids.
SUBSTANCE: invention proposes the novel derivatives of phenylalanine of the formula (I) and (II) possessing with antagonistic activity with respect to α4-integrin. Derivatives of phenylalanine are used as therapeutic agents in different diseases associated with α4-integrin.
EFFECT: valuable medicinal properties of compounds.
37 cl, 30 tbl, 215 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL PHENYLALANINE DERIVATIVES | 2004 |
|
RU2390520C2 |
p-PHENYLENEDIAMINE DERIVATIVE AS POTASSIUM CHANNEL REGULATOR, METHOD FOR ITS PRODUCTION AND MEDICAL USE | 2019 |
|
RU2762562C1 |
NOVEL PYRROLIDINE COMPOUND AND APPLICATION AS MELANOCORTIN RECEPTOR AGONIST | 2015 |
|
RU2669938C2 |
DERIVATIVES OF DIARYLIC ACID AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2267484C2 |
BENZOFURAN DERIVATIVES | 2003 |
|
RU2286344C2 |
METHOD OF PRODUCING PHENYLALANINE DERIVATIVES WITH QUINAZOLINEDIONE SKELETON AND INTERMEDIATE COMPOUNDS USED TO PRODUCE SAID COMPOUNDS | 2007 |
|
RU2469028C2 |
AZAINDOLE DERIVATIVE | 2015 |
|
RU2649575C1 |
SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF | 2014 |
|
RU2667520C9 |
HETEROARYLCARBOXYLIC ACID ESTER DERIVATIVES | 2013 |
|
RU2664544C2 |
EGFR INHIBITOR | 2021 |
|
RU2817044C1 |
Authors
Dates
2006-10-27—Published
2001-08-15—Filed